• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • iPSC Quality Assessment Rounds
    • iPSC Quality Assessment Round 2022/2023
      • iPSC Quality Assessment Round 2022 – Document Page
  • Directories
  • Clinical Database
  • Portal Login
You are here: Home / About GAiT

About GAiT

The Global Alliance for iPSC Therapies (GAiT)

Breaching silos to advance iPSC therapies

The Global Alliance for induced Pluripotent Stem Cell Therapies (GAiT) supports the implementation and clinical application of therapies derived from induced pluripotent stem cells to the benefit of patients globally.

  • Cell and Gene Therapy Catapult (UK)
  • INSERM (France)
  • The New York Stem Cell Foundation (USA)
  • University of Hong Kong (Hong Kong)
  • Korean HLA-typed iPSC Banking Initiative (Korea)
  • Center for Commercialisation of Regenerative Medicine (Canada)

GAiT activity is funded by a global consortium  of organisations: the New York Stem Cell Foundation (New York, USA), the Cell and Gene Therapy Catapult (London, UK) the Centre for Commercialization of Regenerative Medicine (Toronto, Canada), the Korean HLA-Typed iPSC Banking Initiative (Seoul, Korea), the French Institute of Health and Medical Research INSERM (Paris, France), and the University of Hong Kong (Hong Kong, Hong Kong).

More information on GAiT is available in this recently published open access article here.

GAiT’s mission

GAiT serves as a central, international resource for those organisations who are developing therapies from clinical-grade induced pluripotent stem cells and to support the expansion of this nascent field.

With the support of its international partners, GAiT already has an early position on manufacturing, regulatory and quality standards, and GAiT’s intention is to support the delivery of the next generation of cell therapies.

More information on GAiT mission is available here.

GAiT (Global Alliance for iPSC Therapies)
Scottish Office
The Jack Copland Centre
52 Research Avenue North
Heriot-Watt Research Park
Edinburgh
EH14 4BE
UK.

Directions from Edinburgh Waverley Station

Directions from Edinburgh Airport

Primary Sidebar

Search Users

GAiT News

Find us on Twitter
IPSCtherapies avatar; GAiT @IPSCtherapies ·
15 Dec 1603361474143035396

GAiT joins CCRM on their latest podcast to discuss the clinical potential of induced Pluripotent Stem Cells

Image for twitter card

‎Commercializing Living Therapies with CCRM: Unlocking the potential of induced pluripotent stem...

‎Show Commercializing Living Therapies with CCRM, Ep Unlocking the potential of induced pluripotent stem cells - Dec 14, 2022

podcasts.apple.com

Reply on Twitter 1603361474143035396 Retweet on Twitter 1603361474143035396 0 Like on Twitter 1603361474143035396 0 Twitter 1603361474143035396
IPSCtherapies avatar; GAiT @IPSCtherapies ·
22 Aug 1561763439541981184

https://advancedtherapiesweek.phacilitate.com/

Image for the Tweet beginning:  Twitter feed image.
Reply on Twitter 1561763439541981184 Retweet on Twitter 1561763439541981184 0 Like on Twitter 1561763439541981184 1 Twitter 1561763439541981184
IPSCtherapies avatar; GAiT @IPSCtherapies ·
22 Aug 1561760752645672960

GAiT looks forward to speaking to Indian Colleagues from CMC Vellore at the 7th Cell and Gene Therapy Symposium 1st -3rd September 2022. http://www.cscr.res.in/symposium

Reply on Twitter 1561760752645672960 Retweet on Twitter 1561760752645672960 0 Like on Twitter 1561760752645672960 1 Twitter 1561760752645672960
Load More...

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2023 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login